Editorially Independent content supported with advertising by Novartis and Alcon.

Outside-the-Box Therapy for Wet AMD

Christopher G. Fuller, MD

Show Description +

Christopher G. Fuller, MD, shares a case of a monocular patient whose long-term wet AMD was managed with anti-VEGF therapy. As the patient's disease destabilized, cystic edema presented, and anti-VEGF agents proved less effective, leading Dr. Fuller to administer an intravitreal dexamethasone implant 0.7 mg (Ozurdex, Allergan). Hear a panel of experts discuss this case on the New Retina Radio miniseries The Art of Drug Choice: Wet AMD and the Latest Data.

Posted: 10/22/2020

Keywords:

Wet AMD

Up Next

The Value of Treatment Options in Wet AMD

Justus G. Garweg, MD

Switching to a New Anti-VEGF Agent Early in the Course of Therapy

Seenu M. Hariprasad, MD

Extending Duration in a Patient With Polypoidal Choroidal Vasculopathy

Peter Kertes, MD, FRCS(C)

Managing a Patient With High Treatment Burden and a History of Intraocular Inflammation

Arshad M. Khanani, MD, MA

Management of IOI After Anti-VEGF Therapy in a 12-year Wet AMD Patient

Arshad M. Khanani, MD, MA

Switching Agents Multiple Times in a Long-term Wet AMD Patient

Lejla Vajzovic, MD

Extending Treatment Intervals in a 90-Year-Old Wet AMD Patient

Joseph M. Coney, MD

Increasing Treatment Intervals in Wet AMD

Arshad M. Khanani, MD

A Breakthrough After Monthly Wet AMD Therapy

Nikolas J.S. London, MD

Navigating Treatment Burden in Wet AMD

Christina Weng, MD, MBA

Back to All Videos

Outside-the-Box Therapy for Wet AMD

Christopher G. Fuller, MD

Posted: 10/22/2020

Keywords:

Wet AMD

Please log in to leave a comment.

Comments

Daniel Kiernan

4 years ago

As you pointed out he was a vasculopath on multiple medications for systemic vascular disorders. My impression, although an FA would be helpful, is that at the point of recalcitrant edema, he had a retinal vein component layered upon this complex picture. Strong work using Ozurdex ti keep this octogenarian upon our noble country’s roads! Beovu in a monocular patient is probably not ideal in this day and age.

Editorial Feature:

The Art of Drug Choice

Outside-the-Box Therapy for Wet AMD

Up Next

Outside-the-Box Therapy for Wet AMD

Comments

Listen as a Podcast